Agios Pharmaceuticals, Inc. AGIO
32.58
(0.32)
(0.97%)
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 0.0×
Follow AGIO
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(27.57%) | (30.20%) | (32.82%) | (34.34%) | |
| (25.26%) | (27.89%) | (30.84%) | (31.89%) | ||
ROIC |
(89.67%) | (87.12%) | (79.88%) | (70.24%) | |
Return on Tangible Assets |
(41.41%) | (47.41%) | (53.73%) | (62.56%) | |
Average Days of Receivables |
40.98 | 71.46 | 89.15 | 74.65 | |
Free Cash Flow per Share |
(7.12) | (6.51) | (6.54) | (6.14) | |
Free Cash Flow |
(414.09) | (377.29) | (384.73) | (365.25) | |
Capital Expenditures |
(4.16) | (4.32) | (4.32) | (4.66) | |
Piotroski F-Score |
2.00 | 2.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(18.32%) | (18.22%) | (20.61%) | (21.94%) | |
Accounts Receivable Turnover |
11.00 | 7.36 | 6.78 | 7.84 | |
Accounts Payable Turnover |
0.31 | 0.36 | 0.48 | 0.46 | |
Inventory Turnover |
0.20 | 0.21 | 0.20 | 0.26 | |
Average Days of Payables |
1,246.39 | 1,055.88 | 762.68 | 757.77 | |
Days of Inventory on Hand |
2,041.99 | 1,893.74 | 1,946.61 | 1,397.88 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
746.33% | 628.44% | 526.80% | 362.78% | |
Selling, General and Administrative Expense of Revenue |
402.69% | 333.68% | 283.21% | 195.99% | |
Share Based Compensation of Revenue |
110.14% | 97.27% | 85.90% | 58.96% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.02 | 0.90 | 0.90 | 0.88 | |
Depreciation/Fixed assets |
(0.54) | (0.19) | (0.16) | (0.03) | |
Capex/Depreciation |
0.72 | 2.14 | 2.50 | 13.50 | |
Revenue per Share |
0.77 | 0.93 | 1.12 | 1.65 | |
Operating CF per Share |
(7.05) | (6.43) | (6.47) | (6.06) | |
Capex per Share |
(0.07) | (0.07) | (0.07) | (0.08) | |
Capex to Sales |
0.09 | 0.08 | 0.07 | 0.05 | |
Net Profit Margin |
(895.86%) | (764.01%) | (639.84%) | (418.24%) |
Columns are period end dates